Single-domain antibody bioconjugated near-IR quantum dots for targeted cellular imaging of pancreatic cancer

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 5, 2011, Pages 3757-3763

  Zaman, Md Badruz ^a   Baral, Toya Nath ^a   Jakubek, Zygmunt J ^a   Zhang, Jianbing ^a   Wu, Xiaohua ^a   Lai, Edward ^b   Whitfield, Dennis ^a   Yu, Kui ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Colloidal nanocrystals; In vitro targeted cellular imaging; Pancreatic and breast cancer; Photoluminescent near IR quantum dots (QDS); Single domain antibody

Indexed keywords

BREAST CANCER; COLLOIDAL NANOCRYSTALS; IN-VITRO; PHOTOLUMINESCENT NEAR-IR QUANTUM DOTS (QDS); SINGLE DOMAINS;

DISEASES; MOLECULAR IMAGING; SEMICONDUCTOR QUANTUM DOTS;

ANTIBODIES;

ANTIBODY CONJUGATE; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; DIAGNOSTIC AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; QUANTUM DOT;

ARTICLE; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOLOGY; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE, TUMOR; GPI-LINKED PROTEINS; HUMANS; IMMUNOCONJUGATES; MICROSCOPY, FLUORESCENCE; PANCREATIC NEOPLASMS; QUANTUM DOTS; SPECTROSCOPY, NEAR-INFRARED;

EID: 80051596401     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.4167     Document Type: Conference Paper

References (31)

1. M. Bruchez, Jr., M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos, Science 281, 2013(1998).
2. W. C. W. Chan and S. Nie, Science 281, 2016(1998).
3. X. Michalet, F. F. Pinaud, L. A. J. Bentolila, M. Tsay, S. Doose, J. J. Li, G. Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss, Science 307, 538(2005).
4. M. B. Zaman, T. N. Baral, J. Zhang, D. Whitfield, and K. Yu, J. Phys. Chem. C 113, 496(2009).
5. S. Kim, Y. T. Lim, E. G. Soltesz, A. M. De Grand, J. Lee, A. Nakayama, J. A. Parker, T. Mihaljevic, R. G. Laurence, D. M. Dor, L. H. Cohn, M. G. Bawendi, and J. V. Frangioni, Nat. Biotechnol. 22, 93(2003).
6. (a) J. Sun, M. Q. Zhu, K. Fu, N. Lewinski, and R. A. Drezek, International J. Nanomedicine 2, 235(2007);
7. (b) K. T. Yong, Nanotechnology 20, 015102(2009);
8. (c) C. Shi, Y. Zhu, Z. Xie, W. Qian, C. L. Hsleh, S. Nie, Y. Su, H. E. Zhau, and L. W. K. Chung, J. Urology 74, 446(2009);
9. (d) P. M. Allen, W. Liu, V. P. Chauhan, J. Lee, A. Y. Ting, D. Fukumura, R. K. Jain, and M. G. Bawendi, J. Am. Chem. Soc. 132, 470(2010).
10. H. Kobayashi, M. Ogawa, R. Alford, P. L. Choyke, and Y. Urano, Chem. Rev. 110, 2620(2010).
11. R. E. Bailey and S. Nie, J. Am. Chem. Soc. 125, 7100(2003).
12. (a) K. Yu, B. Zaman, S. Romanova, D. Wang, J. A. Ripmeester, Small 3, 332(2005);
13. (b) C. I. Ratcliffe, K. Yu, J. A. Ripmeester, M. B. Zaman, C. Badarau, and S. Singh, Phys. Chem. Chem. Phys. 8, 3510(2006).
14. W. Jiang, A. Singhal, J. Zheng, C. Wang, and W. C. W. Chan, Chem. Mater. 18, 4845(2006).
15. K. T. Yong, I. Roy, H. Ding, E. J. Eergey, and P. N. Prasad, Small 5, 1997(2004).
16. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, CA Cancer J. Clin. 59, 225(2009).
17. R. D. Blumenthal, E. Leon, H. J. Hansen, and D. M. Goldenberg, BMC Cancer 7, 2(2007).
18. M. S. Duxbury, H. Ito, S. W. Ashley, and E. E. Whang, J. Biol. Chem. 279, 23176(2004).
19. M. Tempero, W. Plunkett, V. R. Van Haperen, J. Hainsworth, H. Hochster, R. Lenzi, and J. Abbruzzese, J. Clin. Oncol. 21, 3402(2003).
20. C. Hamers-Casterman, T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers, E. B. Songa, N. Bendahman, and R. Hamers, Nature 363, 446(1993).
21. M. A. Ghahroudi, A. Desmyter, L. Wyns, R. Hamers, and S. Muyldermans, FEBS Lett. 414, 521(1997).
22. S. Li, W. Zheng, R. Kuolee, T. Hirama, M. Henry, S. Makvandi-Nejad, T. Fjallman, W. Chen, and J. Zhang, Mol. Immunol. 46, 1718(2009).
23. M. Dumoulin, K. Conrath, A. Van Meirhaeghe, F. Meersman, K. Heremans, L. G. Frenken, S. Muyldermans, L. Wyns, and A. Matagne, Protein Sci. 11, 500(2002).
24. V. Cortez-Retamozo, M. Lauwereys, G. Hassanzadeh Gh, M. Gobert, K. Conrath, S. Muyldermans, P. De Baetselier, and H. Revets, Int. J. Cancer 98, 456(2002).
25. R. C. Roovers, T. Laeremans, L. Huang, S. De Taeye, A. J. Verkleij, H. Revets, H. J. de Haard, and P. M. van Bergen en Henegouwen, Cancer Immunol. Immunother. 56, 303(2007).
26. (a) J. Zhang, M. O'Connor-McCourt, T. N. Baral, and Y. Murad, Anti-Cecam6 Antibodies and Uses Thereof, US Provisional Application No. 61/388, 746 filed on October 1, (2010);
27. (b) T. N. Baral, Y. Murad, T. D. Nguyen, and J. Zhang, Isolation of functional single domain antibody by whole cell immunization: Implications for cancer treatment submitted to Molecular immunology.
28. (b) J. Zhang, Q. Li, T. D. Nguyen, T. L. Tremblay, E. Stone, R. To, J. Kelly, and R. C. MacKenzie, J. Mol. Biol. 341, 161(2004).
29. G. T. Hermanson, Bioconjugate Techniques, 2nd edn., Elsevier Science, San Diego, CA (2008), pp. 216-223.
30. M. S. Duxbury, H. Ito, E. Benoit, S. W. Ashley, and E. E. Whang, British Journal of Cancer 91, 1384(2004).
31. R. E. Payne, E. Yagüe, M. J. Slade, C. Apostolopoulos, L. R. Jiao, B. Ward, R. C. Coombes, and J. Stebbing, Pharmacogenomics 10, 51(2009).